Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Piotrkow Trybunalski – page 2

47 clinical trials in Piotrkow Trybunalski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Piotrkow Trybunalski at a glance
47
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

47 trials in Piotrkow Trybunalski

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bicalutamide
  • Sponsor:Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Angina pectoris

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
  • Sponsor:Tasly Pharmaceuticals Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Piotrkow Trybunalski

What the registry says about research in the country

01 Oncology Research

Studies focusing on innovative treatments for bladder cancer, including combinations with immunotherapy agents and novel therapeutic approaches for head and neck cancer. Multiple trials are evaluating new combination therapies for prostate cancer.

  • Non-muscle invasive bladder cancer treatments
  • Head and neck squamous cell carcinoma therapies
  • Metastatic prostate cancer interventions

Research emphasizes improving survival rates and treatment outcomes through targeted therapies.

02 Cardiovascular Studies

Comprehensive research into heart failure treatments, particularly focusing on reduced ejection fraction conditions. Studies evaluate new medications for stroke prevention in patients with atrial fibrillation.

  • Heart failure management strategies
  • Stroke prevention therapies
  • Cardiovascular disease prevention

Trials aim to improve patient outcomes and develop more effective treatment options.

03 Autoimmune Conditions

Innovative research targeting multiple sclerosis, rheumatoid arthritis, and Sjögren's syndrome. Studies evaluate novel therapeutic approaches and biosimilar medications.

  • Multiple sclerosis treatments
  • Rheumatoid arthritis therapies
  • Inflammatory bowel disease interventions

Focus on developing targeted treatments to improve disease management and patient quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.